Uveitic Macular Edema : Incidence and Risk Factors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210519002

Enrollment

350

Registered

2021-05-19

Start date

2020-02-28

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uveitis patients with and without uveitic macular edema uveitis macular edema

Interventions

Uvieitis patients without UME,Uveitis patients with UME

Health Services Research,Health Services Research

No UME,UME

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who was diagnosed with uveitis 2. Follow up more than 6 months 3. Presented of macular OCT (Heidelberg spectralist)

Exclusion criteria

Exclusion criteria: 1. Patients who received prior treatment from other hospitals 2. DM 3. Retinal vascular occlusion 4. Wet AMD

Design outcomes

Primary

Measure	Time frame
uveitic macular edema 6 months Ocular coherence tomograpghy	—

Secondary

Measure	Time frame
Risk factors 6 months Factors related to uveitis	—

Countries

Thailand

Contacts

Public ContactSutasinee Boonsopon

Siriraj hospital, Mahidol University

sutasinee.boo@mahidol.edu024198033

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026